Literature DB >> 29700490

IDO takes a blow.

Asher Mullard.   

Abstract

Entities:  

Year:  2018        PMID： 29700490     DOI： 10.1038/nrd.2018.67

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

Review 1.  Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers.

Authors:  Takefumi Komiya; Chao H Huang
Journal:  Front Oncol       Date:  2018-10-04       Impact factor: 6.244

Review 2.  The T-win® technology: immune-modulating vaccines.

Authors:  Mads Hald Andersen
Journal:  Semin Immunopathol       Date:  2018-07-02       Impact factor: 9.623

3.  Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy.

Authors:  Liping Zhang; Emily C Cherney; Xiao Zhu; Tai-An Lin; Johnni Gullo-Brown; Derrick Maley; Kathy Johnston-Allegretto; Lisa Kopcho; Mark Fereshteh; Christine Huang; Xin Li; Sarah C Traeger; Gopal Dhar; Aravind Anandam; Sandeep Mahankali; Shweta Padmanabhan; Prabhakar Rajanna; Venkata Murali; Thanga Mariappan; Robert Borzilleri; Gregory Vite; John T Hunt; Aaron Balog
Journal:  ACS Med Chem Lett       Date:  2021-03-02       Impact factor: 4.345

Review 4.  Targeting the IDO1 pathway in cancer: from bench to bedside.

Authors:  Ming Liu; Xu Wang; Lei Wang; Xiaodong Ma; Zhaojian Gong; Shanshan Zhang; Yong Li
Journal:  J Hematol Oncol       Date:  2018-08-02       Impact factor: 17.388

5.  Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Authors:  Maria Georganaki; Mohanraj Ramachandran; Sander Tuit; Nicolás Gonzalo Núñez; Alexandros Karampatzakis; Grammatiki Fotaki; Luuk van Hooren; Hua Huang; Roberta Lugano; Thomas Ulas; Aura Kaunisto; Eric C Holland; Peter Ellmark; Sara M Mangsbo; Joachim Schultze; Magnus Essand; Sonia Tugues; Anna Dimberg
Journal:  Oncoimmunology       Date:  2020-03-09       Impact factor: 8.110

6.  IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation.

Authors:  Adaobi Amobi-McCloud; Ravikumar Muthuswamy; Sebastiano Battaglia; Han Yu; Tao Liu; Jianmin Wang; Vasanta Putluri; Prashant K Singh; Feng Qian; Ruea-Yea Huang; Nagireddy Putluri; Takemasa Tsuji; Amit A Lugade; Song Liu; Kunle Odunsi
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 8.786

7.  Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway.

Authors:  Jeong Hun Kim; Won Suk Lee; Hye Jin Lee; Hannah Yang; Seung Joon Lee; So Jung Kong; Soyeon Je; Hyun-Jin Yang; Jongsun Jung; Jaekyung Cheon; Beodeul Kang; Hong Jae Chon; Chan Kim
Journal:  Oncoimmunology       Date:  2021-11-26       Impact factor: 8.110

8.  Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies.

Authors:  Adekunle Odunsi; A J Robert McGray; Anthony Miliotto; Yali Zhang; Jianming Wang; Adebukola Abiola; Cheryl Eppolito; Ruea-Yea Huang
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

9.  The trans-omics landscape of COVID-19.

Authors:  Peng Wu; Dongsheng Chen; Wencheng Ding; Ping Wu; Hongyan Hou; Yong Bai; Yuwen Zhou; Kezhen Li; Shunian Xiang; Panhong Liu; Jia Ju; Ensong Guo; Jia Liu; Bin Yang; Junpeng Fan; Liang He; Ziyong Sun; Ling Feng; Jian Wang; Tangchun Wu; Hao Wang; Jin Cheng; Hui Xing; Yifan Meng; Yongsheng Li; Yuanliang Zhang; Hongbo Luo; Gang Xie; Xianmei Lan; Ye Tao; Jiafeng Li; Hao Yuan; Kang Huang; Wan Sun; Xiaobo Qian; Zhichao Li; Mingxi Huang; Peiwen Ding; Haoyu Wang; Jiaying Qiu; Feiyue Wang; Shiyou Wang; Jiacheng Zhu; Xiangning Ding; Chaochao Chai; Langchao Liang; Xiaoling Wang; Lihua Luo; Yuzhe Sun; Ying Yang; Zhenkun Zhuang; Tao Li; Lei Tian; Shaoqiao Zhang; Linnan Zhu; Ashley Chang; Lei Chen; Yiquan Wu; Xiaoyan Ma; Fang Chen; Yan Ren; Xun Xu; Siqi Liu; Jian Wang; Huanming Yang; Lin Wang; Chaoyang Sun; Ding Ma; Xin Jin; Gang Chen
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.